

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.37476531 |
| 2 | respiratory electron transport chain (GO:0022904) | 5.80907812 |
| 3 | electron transport chain (GO:0022900) | 5.68370153 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.60881026 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 5.45558198 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.45558198 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.83926532 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.83926532 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.71505064 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 4.71505064 |
| 11 | aldehyde catabolic process (GO:0046185) | 4.37472796 |
| 12 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.19005184 |
| 13 | protein maturation by protein folding (GO:0022417) | 3.99725543 |
| 14 | NADH metabolic process (GO:0006734) | 3.89766481 |
| 15 | protein complex biogenesis (GO:0070271) | 3.89579281 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 3.76604915 |
| 17 | respiratory chain complex IV assembly (GO:0008535) | 3.76402569 |
| 18 | alkaloid metabolic process (GO:0009820) | 3.75719888 |
| 19 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.68533964 |
| 20 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.68533964 |
| 21 | NADH dehydrogenase complex assembly (GO:0010257) | 3.68533964 |
| 22 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.66696233 |
| 23 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.58537660 |
| 24 | cellular response to zinc ion (GO:0071294) | 3.48822499 |
| 25 | omega-hydroxylase P450 pathway (GO:0097267) | 3.47041051 |
| 26 | flavonoid metabolic process (GO:0009812) | 3.42718798 |
| 27 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.39737556 |
| 28 | cytochrome complex assembly (GO:0017004) | 3.39118538 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 3.36989400 |
| 30 | oxidative phosphorylation (GO:0006119) | 3.34090551 |
| 31 | inner mitochondrial membrane organization (GO:0007007) | 3.33415043 |
| 32 | ribosomal small subunit biogenesis (GO:0042274) | 3.32547298 |
| 33 | viral transcription (GO:0019083) | 3.30433026 |
| 34 | ATP biosynthetic process (GO:0006754) | 3.28279764 |
| 35 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.27328249 |
| 36 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.25242546 |
| 37 | hydrogen ion transmembrane transport (GO:1902600) | 3.22706668 |
| 38 | glucuronate metabolic process (GO:0019585) | 3.22622004 |
| 39 | uronic acid metabolic process (GO:0006063) | 3.22622004 |
| 40 | glutathione biosynthetic process (GO:0006750) | 3.22139065 |
| 41 | short-chain fatty acid metabolic process (GO:0046459) | 3.21654853 |
| 42 | chaperone-mediated protein transport (GO:0072321) | 3.20793484 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 3.17782215 |
| 44 | GTP biosynthetic process (GO:0006183) | 3.14612284 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 3.13592809 |
| 46 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.09284021 |
| 47 | translational termination (GO:0006415) | 3.08529461 |
| 48 | tyrosine metabolic process (GO:0006570) | 3.07252189 |
| 49 | glyoxylate metabolic process (GO:0046487) | 3.05145183 |
| 50 | cotranslational protein targeting to membrane (GO:0006613) | 3.04087028 |
| 51 | oxaloacetate metabolic process (GO:0006107) | 3.03461231 |
| 52 | coenzyme catabolic process (GO:0009109) | 3.03367580 |
| 53 | aerobic respiration (GO:0009060) | 3.02289423 |
| 54 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.02107158 |
| 55 | fatty acid catabolic process (GO:0009062) | 3.02004817 |
| 56 | protein targeting to mitochondrion (GO:0006626) | 3.01635414 |
| 57 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.01363290 |
| 58 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.99857556 |
| 59 | protein targeting to ER (GO:0045047) | 2.98920360 |
| 60 | indole-containing compound catabolic process (GO:0042436) | 2.97615166 |
| 61 | indolalkylamine catabolic process (GO:0046218) | 2.97615166 |
| 62 | tryptophan catabolic process (GO:0006569) | 2.97615166 |
| 63 | proton transport (GO:0015992) | 2.97609965 |
| 64 | dopamine transport (GO:0015872) | 2.96270946 |
| 65 | hydrogen transport (GO:0006818) | 2.93524557 |
| 66 | establishment of protein localization to mitochondrion (GO:0072655) | 2.92860675 |
| 67 | ketone body metabolic process (GO:1902224) | 2.92855224 |
| 68 | sulfur amino acid catabolic process (GO:0000098) | 2.92712436 |
| 69 | protein localization to endoplasmic reticulum (GO:0070972) | 2.92346634 |
| 70 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.91522697 |
| 71 | urea cycle (GO:0000050) | 2.90326487 |
| 72 | urea metabolic process (GO:0019627) | 2.90326487 |
| 73 | bile acid biosynthetic process (GO:0006699) | 2.89853345 |
| 74 | proline biosynthetic process (GO:0006561) | 2.89709364 |
| 75 | fatty acid beta-oxidation (GO:0006635) | 2.87854707 |
| 76 | nitrogen cycle metabolic process (GO:0071941) | 2.87843416 |
| 77 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.87805866 |
| 78 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.87489056 |
| 79 | polyketide metabolic process (GO:0030638) | 2.86769407 |
| 80 | doxorubicin metabolic process (GO:0044598) | 2.86769407 |
| 81 | daunorubicin metabolic process (GO:0044597) | 2.86769407 |
| 82 | vitamin biosynthetic process (GO:0009110) | 2.86686813 |
| 83 | protein neddylation (GO:0045116) | 2.86402989 |
| 84 | cysteine metabolic process (GO:0006534) | 2.86282078 |
| 85 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.85567760 |
| 86 | regulation of mitochondrial translation (GO:0070129) | 2.85388763 |
| 87 | proteasome assembly (GO:0043248) | 2.84333855 |
| 88 | cellular glucuronidation (GO:0052695) | 2.83802376 |
| 89 | monocarboxylic acid catabolic process (GO:0072329) | 2.83717145 |
| 90 | serine family amino acid catabolic process (GO:0009071) | 2.83231156 |
| 91 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.82852736 |
| 92 | ethanol oxidation (GO:0006069) | 2.82849037 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.82764063 |
| 94 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.82126560 |
| 95 | GDP-mannose metabolic process (GO:0019673) | 2.81935372 |
| 96 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.80268350 |
| 97 | ubiquinone biosynthetic process (GO:0006744) | 2.80259445 |
| 98 | quinone biosynthetic process (GO:1901663) | 2.80259445 |
| 99 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.79058780 |
| 100 | branched-chain amino acid catabolic process (GO:0009083) | 2.78101513 |
| 101 | arginine metabolic process (GO:0006525) | 2.77982671 |
| 102 | fructose metabolic process (GO:0006000) | 2.77797319 |
| 103 | negative regulation of ligase activity (GO:0051352) | 2.76612010 |
| 104 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.76612010 |
| 105 | mitochondrial transport (GO:0006839) | 2.75068146 |
| 106 | cofactor catabolic process (GO:0051187) | 2.74786954 |
| 107 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.74664008 |
| 108 | protein carboxylation (GO:0018214) | 2.73203899 |
| 109 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.73203899 |
| 110 | glutathione derivative metabolic process (GO:1901685) | 2.72253148 |
| 111 | glutathione derivative biosynthetic process (GO:1901687) | 2.72253148 |
| 112 | tryptophan metabolic process (GO:0006568) | 2.72202018 |
| 113 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.72003518 |
| 114 | organic acid catabolic process (GO:0016054) | 2.70941422 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 2.70941422 |
| 116 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.70938559 |
| 117 | epoxygenase P450 pathway (GO:0019373) | 2.69275374 |
| 118 | fatty acid oxidation (GO:0019395) | 2.68399341 |
| 119 | cellular biogenic amine catabolic process (GO:0042402) | 2.68197470 |
| 120 | amine catabolic process (GO:0009310) | 2.68197470 |
| 121 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.68003179 |
| 122 | termination of RNA polymerase III transcription (GO:0006386) | 2.68003179 |
| 123 | response to nitrosative stress (GO:0051409) | 2.67906802 |
| 124 | regulation of triglyceride catabolic process (GO:0010896) | 2.67794207 |
| 125 | ethanol metabolic process (GO:0006067) | 2.67775958 |
| 126 | NAD biosynthetic process (GO:0009435) | 2.67718262 |
| 127 | protein localization to mitochondrion (GO:0070585) | 2.67323934 |
| 128 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.67150536 |
| 129 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.65952106 |
| 130 | lipid oxidation (GO:0034440) | 2.65845348 |
| 131 | kynurenine metabolic process (GO:0070189) | 2.65214044 |
| 132 | arginine catabolic process (GO:0006527) | 2.64852069 |
| 133 | bile acid and bile salt transport (GO:0015721) | 2.64184176 |
| 134 | alpha-amino acid catabolic process (GO:1901606) | 2.62979305 |
| 135 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.61356021 |
| 136 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.61356021 |
| 137 | mitochondrial calcium ion transport (GO:0006851) | 2.61255114 |
| 138 | regulation of cellular amine metabolic process (GO:0033238) | 2.60537116 |
| 139 | regulation of oxidative phosphorylation (GO:0002082) | 2.58556387 |
| 140 | cellular amino acid catabolic process (GO:0009063) | 2.58152470 |
| 141 | cellular response to cadmium ion (GO:0071276) | 2.57896890 |
| 142 | glutathione metabolic process (GO:0006749) | 2.57150437 |
| 143 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.55369741 |
| 144 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.55369741 |
| 145 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.55369741 |
| 146 | mitotic nuclear envelope reassembly (GO:0007084) | 2.53639186 |
| 147 | nuclear envelope reassembly (GO:0031468) | 2.53639186 |
| 148 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.51781030 |
| 149 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.51781030 |
| 150 | proline metabolic process (GO:0006560) | 2.50928075 |
| 151 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.48694144 |
| 152 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.48694144 |
| 153 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.48688678 |
| 154 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.48353853 |
| 155 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.48353853 |
| 156 | angiotensin maturation (GO:0002003) | 2.48222516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.11403842 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.91383094 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.07347809 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.79995152 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.58898375 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.53013157 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.39090415 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.19638239 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.18664618 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.00577372 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.36850038 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.35228754 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.35215222 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.33823220 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28775174 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.27043308 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26776959 |
| 18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.20045968 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.13684565 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.09384323 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.09362085 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.95614074 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95097798 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.89517823 |
| 25 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.85501188 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.84293752 |
| 27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.81258639 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77602019 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77541044 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.76753677 |
| 31 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.73996083 |
| 32 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.73578901 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.71533408 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68438652 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.63963914 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.60575163 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60038742 |
| 38 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.55295170 |
| 39 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.54820958 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.54163984 |
| 41 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.53933546 |
| 42 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.53320935 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52823012 |
| 44 | P68_20966046_ChIP-Seq_HELA_Human | 1.50461071 |
| 45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49473890 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46600698 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45335518 |
| 48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.43913372 |
| 49 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.41827164 |
| 50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.39088557 |
| 51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38721990 |
| 52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38702496 |
| 53 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34742031 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32242669 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29876987 |
| 56 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.29011157 |
| 57 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28087640 |
| 58 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.27742708 |
| 59 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27428825 |
| 60 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26852503 |
| 61 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.25106096 |
| 62 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.23767190 |
| 63 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.23588024 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22975701 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20397118 |
| 66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.20193076 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19446449 |
| 68 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19065662 |
| 69 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.18533736 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18069946 |
| 71 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.17295161 |
| 72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17198020 |
| 73 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16603486 |
| 74 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.16567146 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16093509 |
| 76 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15711620 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14889242 |
| 78 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14880137 |
| 79 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14778962 |
| 80 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.14666717 |
| 81 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.14360178 |
| 82 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.14241260 |
| 83 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14054123 |
| 84 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.13761878 |
| 85 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.13248759 |
| 86 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.11429029 |
| 87 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08933843 |
| 88 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08831509 |
| 89 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.07833658 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07710621 |
| 91 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.07231145 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07122756 |
| 93 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06910991 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06878937 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06698820 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06243149 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05841580 |
| 98 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05684208 |
| 99 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05063429 |
| 100 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04992066 |
| 101 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04885905 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03807683 |
| 103 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03621423 |
| 104 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.03221033 |
| 105 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.03169080 |
| 106 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02198536 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01603961 |
| 108 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01518586 |
| 109 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01507043 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01210072 |
| 111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99479162 |
| 112 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99441248 |
| 113 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98921600 |
| 114 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97554044 |
| 115 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96610076 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96244102 |
| 117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.95933454 |
| 118 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.95727353 |
| 119 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.95505565 |
| 120 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95370468 |
| 121 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.95254202 |
| 122 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95032234 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90768936 |
| 124 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.88981362 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87955649 |
| 126 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.87121796 |
| 127 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.87121796 |
| 128 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.87121796 |
| 129 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87105713 |
| 130 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.87052358 |
| 131 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.87040114 |
| 132 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.86584574 |
| 133 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86461040 |
| 134 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.85235911 |
| 135 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85068077 |
| 136 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84268650 |
| 137 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82103122 |
| 138 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.81650578 |
| 139 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.80956347 |
| 140 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.80869875 |
| 141 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79961798 |
| 142 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.79298155 |
| 143 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78947137 |
| 144 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78635101 |
| 145 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78585279 |
| 146 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.75582335 |
| 147 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.74428330 |
| 148 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.73556495 |
| 149 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.73159006 |
| 150 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.73124832 |
| 151 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.72626084 |
| 152 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.72600130 |
| 153 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.72025623 |
| 154 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.72025623 |
| 155 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70238070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.50376269 |
| 2 | MP0005360_urolithiasis | 4.83393885 |
| 3 | MP0009379_abnormal_foot_pigmentation | 4.28851448 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.97574310 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.89063965 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.43514307 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.30859087 |
| 8 | MP0005365_abnormal_bile_salt | 2.96463275 |
| 9 | MP0003195_calcinosis | 2.46213663 |
| 10 | MP0003136_yellow_coat_color | 2.34913167 |
| 11 | MP0005332_abnormal_amino_acid | 2.34788596 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.33761418 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.32083910 |
| 14 | MP0006276_abnormal_autonomic_nervous | 2.25983002 |
| 15 | MP0003724_increased_susceptibility_to | 2.24069218 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.15210487 |
| 17 | MP0002822_catalepsy | 2.14637123 |
| 18 | MP0005083_abnormal_biliary_tract | 2.04748322 |
| 19 | MP0003868_abnormal_feces_composition | 1.94478607 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.88631910 |
| 21 | MP0001666_abnormal_nutrient_absorption | 1.87368185 |
| 22 | MP0003186_abnormal_redox_activity | 1.83680262 |
| 23 | MP0003252_abnormal_bile_duct | 1.82014952 |
| 24 | MP0001529_abnormal_vocalization | 1.79552098 |
| 25 | MP0001188_hyperpigmentation | 1.79253313 |
| 26 | MP0005409_darkened_coat_color | 1.78507894 |
| 27 | MP0005084_abnormal_gallbladder_morpholo | 1.74203015 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.71338089 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.71008209 |
| 30 | MP0003880_abnormal_central_pattern | 1.69589243 |
| 31 | MP0001873_stomach_inflammation | 1.68898412 |
| 32 | MP0003011_delayed_dark_adaptation | 1.61819256 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.61789684 |
| 34 | MP0001905_abnormal_dopamine_level | 1.61187958 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.55438344 |
| 36 | MP0001764_abnormal_homeostasis | 1.53691005 |
| 37 | MP0000372_irregular_coat_pigmentation | 1.51611616 |
| 38 | MP0003075_altered_response_to | 1.49205988 |
| 39 | MP0009840_abnormal_foam_cell | 1.44185763 |
| 40 | MP0004142_abnormal_muscle_tone | 1.43971933 |
| 41 | MP0001756_abnormal_urination | 1.40565450 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40301416 |
| 43 | MP0001968_abnormal_touch/_nociception | 1.39902516 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.38761001 |
| 45 | MP0009697_abnormal_copulation | 1.36715425 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.36712203 |
| 47 | MP0001853_heart_inflammation | 1.35885531 |
| 48 | MP0001661_extended_life_span | 1.35278902 |
| 49 | MP0002736_abnormal_nociception_after | 1.35122141 |
| 50 | MP0005330_cardiomyopathy | 1.34720397 |
| 51 | MP0004858_abnormal_nervous_system | 1.34082362 |
| 52 | MP0004381_abnormal_hair_follicle | 1.32668164 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.31220048 |
| 54 | MP0003646_muscle_fatigue | 1.31067677 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.30476009 |
| 56 | MP0004043_abnormal_pH_regulation | 1.24785363 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.23802877 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.23325995 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 1.22134807 |
| 60 | MP0005319_abnormal_enzyme/_coenzyme | 1.19405621 |
| 61 | MP0003123_paternal_imprinting | 1.18848693 |
| 62 | MP0000343_altered_response_to | 1.17404304 |
| 63 | MP0002735_abnormal_chemical_nociception | 1.17046759 |
| 64 | MP0001664_abnormal_digestion | 1.16626561 |
| 65 | MP0005166_decreased_susceptibility_to | 1.16337692 |
| 66 | MP0005535_abnormal_body_temperature | 1.15795960 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.09259573 |
| 68 | MP0001881_abnormal_mammary_gland | 1.08231865 |
| 69 | MP0005408_hypopigmentation | 1.08024368 |
| 70 | MP0000858_altered_metastatic_potential | 1.06734675 |
| 71 | MP0008872_abnormal_physiological_respon | 1.04654199 |
| 72 | MP0002733_abnormal_thermal_nociception | 1.03739112 |
| 73 | MP0002796_impaired_skin_barrier | 1.03720640 |
| 74 | MP0003866_abnormal_defecation | 1.02989822 |
| 75 | MP0005501_abnormal_skin_physiology | 1.02202397 |
| 76 | MP0010386_abnormal_urinary_bladder | 1.02105826 |
| 77 | MP0000490_abnormal_crypts_of | 1.00890679 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.99702347 |
| 79 | MP0001970_abnormal_pain_threshold | 0.98706350 |
| 80 | MP0010155_abnormal_intestine_physiology | 0.97304782 |
| 81 | MP0004147_increased_porphyrin_level | 0.97226644 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.96327459 |
| 83 | MP0005266_abnormal_metabolism | 0.96299513 |
| 84 | MP0001663_abnormal_digestive_system | 0.96082612 |
| 85 | MP0002132_abnormal_respiratory_system | 0.95487890 |
| 86 | MP0000609_abnormal_liver_physiology | 0.94882468 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.94263361 |
| 88 | MP0004510_myositis | 0.93806189 |
| 89 | MP0005451_abnormal_body_composition | 0.93079620 |
| 90 | MP0006082_CNS_inflammation | 0.91822576 |
| 91 | MP0000681_abnormal_thyroid_gland | 0.90059260 |
| 92 | MP0009785_altered_susceptibility_to | 0.89588711 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.89311066 |
| 94 | MP0005376_homeostasis/metabolism_phenot | 0.88738709 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.88107033 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.87938132 |
| 97 | MP0001440_abnormal_grooming_behavior | 0.85631684 |
| 98 | MP0003786_premature_aging | 0.85506847 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.84097360 |
| 100 | MP0002734_abnormal_mechanical_nocicepti | 0.83203803 |
| 101 | MP0002751_abnormal_autonomic_nervous | 0.83002173 |
| 102 | MP0002160_abnormal_reproductive_system | 0.82798734 |
| 103 | MP0003638_abnormal_response/metabolism_ | 0.81335412 |
| 104 | MP0003718_maternal_effect | 0.80566075 |
| 105 | MP0000749_muscle_degeneration | 0.80327348 |
| 106 | MP0005025_abnormal_response_to | 0.80212974 |
| 107 | MP0002272_abnormal_nervous_system | 0.79147730 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.78082492 |
| 109 | MP0003879_abnormal_hair_cell | 0.77320416 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.76994958 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.75959043 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.75636404 |
| 113 | MP0008469_abnormal_protein_level | 0.75258079 |
| 114 | MP0002163_abnormal_gland_morphology | 0.74948319 |
| 115 | MP0003693_abnormal_embryo_hatching | 0.73698404 |
| 116 | MP0008004_abnormal_stomach_pH | 0.72062241 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.71479499 |
| 118 | MP0000747_muscle_weakness | 0.71431733 |
| 119 | MP0008007_abnormal_cellular_replicative | 0.70607723 |
| 120 | MP0006292_abnormal_olfactory_placode | 0.70212902 |
| 121 | MP0000613_abnormal_salivary_gland | 0.69901101 |
| 122 | MP0002067_abnormal_sensory_capabilities | 0.68920520 |
| 123 | MP0005257_abnormal_intraocular_pressure | 0.68463308 |
| 124 | MP0002078_abnormal_glucose_homeostasis | 0.68186311 |
| 125 | MP0005670_abnormal_white_adipose | 0.67923815 |
| 126 | MP0003315_abnormal_perineum_morphology | 0.67099383 |
| 127 | MP0005375_adipose_tissue_phenotype | 0.66763156 |
| 128 | MP0002148_abnormal_hypersensitivity_rea | 0.66319269 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.66220595 |
| 130 | MP0005464_abnormal_platelet_physiology | 0.65703869 |
| 131 | MP0009642_abnormal_blood_homeostasis | 0.65510320 |
| 132 | MP0004742_abnormal_vestibular_system | 0.65299440 |
| 133 | MP0001944_abnormal_pancreas_morphology | 0.65178120 |
| 134 | MP0000751_myopathy | 0.64745808 |
| 135 | MP0005075_abnormal_melanosome_morpholog | 0.64480037 |
| 136 | MP0003959_abnormal_lean_body | 0.64340184 |
| 137 | MP0003191_abnormal_cellular_cholesterol | 0.64287085 |
| 138 | MP0008260_abnormal_autophagy | 0.64160932 |
| 139 | MP0002909_abnormal_adrenal_gland | 0.63974795 |
| 140 | MP0002970_abnormal_white_adipose | 0.63840252 |
| 141 | MP0009764_decreased_sensitivity_to | 0.63801269 |
| 142 | MP0002971_abnormal_brown_adipose | 0.63446057 |
| 143 | MP0003436_decreased_susceptibility_to | 0.63105724 |
| 144 | MP0005165_increased_susceptibility_to | 0.61446323 |
| 145 | MP0005551_abnormal_eye_electrophysiolog | 0.60219127 |
| 146 | MP0003953_abnormal_hormone_level | 0.59943566 |
| 147 | MP0002229_neurodegeneration | 0.59823227 |
| 148 | MP0002332_abnormal_exercise_endurance | 0.59601636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.31416907 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.99636219 |
| 3 | Acute encephalopathy (HP:0006846) | 4.98590276 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.89029949 |
| 5 | Hepatocellular necrosis (HP:0001404) | 4.86305077 |
| 6 | Hepatic necrosis (HP:0002605) | 4.77052989 |
| 7 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.39558681 |
| 8 | Progressive macrocephaly (HP:0004481) | 4.37416066 |
| 9 | Increased CSF lactate (HP:0002490) | 4.34319865 |
| 10 | Cerebral edema (HP:0002181) | 4.34249616 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.31490771 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 4.11428940 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 4.07611322 |
| 14 | Renal Fanconi syndrome (HP:0001994) | 3.92070436 |
| 15 | Increased intramyocellular lipid droplets (HP:0012240) | 3.76763537 |
| 16 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.75768354 |
| 17 | Increased muscle lipid content (HP:0009058) | 3.69129387 |
| 18 | 3-Methylglutaconic aciduria (HP:0003535) | 3.63958520 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.51710039 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.51710039 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.45077074 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.45058480 |
| 23 | Lethargy (HP:0001254) | 3.39332659 |
| 24 | Optic disc pallor (HP:0000543) | 3.34896294 |
| 25 | Lactic acidosis (HP:0003128) | 3.34219616 |
| 26 | Dicarboxylic aciduria (HP:0003215) | 3.20399487 |
| 27 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.20399487 |
| 28 | Hypothermia (HP:0002045) | 3.15534394 |
| 29 | Hyperglycinemia (HP:0002154) | 3.12676331 |
| 30 | Hyperglycinuria (HP:0003108) | 3.11885221 |
| 31 | Respiratory failure (HP:0002878) | 3.11095431 |
| 32 | Exercise intolerance (HP:0003546) | 3.10527191 |
| 33 | Prolonged partial thromboplastin time (HP:0003645) | 3.07745402 |
| 34 | Increased serum lactate (HP:0002151) | 3.05321579 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.02905353 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.02905353 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 3.02905353 |
| 38 | Abnormality of urine glucose concentration (HP:0011016) | 2.96135166 |
| 39 | Glycosuria (HP:0003076) | 2.96135166 |
| 40 | Intrahepatic cholestasis (HP:0001406) | 2.94170447 |
| 41 | Testicular atrophy (HP:0000029) | 2.92115498 |
| 42 | Exertional dyspnea (HP:0002875) | 2.87298986 |
| 43 | Hyperphosphaturia (HP:0003109) | 2.85613243 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77028413 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 2.77028413 |
| 46 | Abnormality of renal resorption (HP:0011038) | 2.75202307 |
| 47 | Hyperammonemia (HP:0001987) | 2.72119008 |
| 48 | Reduced antithrombin III activity (HP:0001976) | 2.63870496 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.62039514 |
| 50 | Hypobetalipoproteinemia (HP:0003563) | 2.53821278 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.51519681 |
| 52 | Leukodystrophy (HP:0002415) | 2.50178716 |
| 53 | Type I transferrin isoform profile (HP:0003642) | 2.48925777 |
| 54 | Axonal loss (HP:0003447) | 2.47910606 |
| 55 | Abnormal urine phosphate concentration (HP:0012599) | 2.45351090 |
| 56 | Methylmalonic aciduria (HP:0012120) | 2.44309309 |
| 57 | Abnormality of glycolysis (HP:0004366) | 2.43853243 |
| 58 | Increased serum pyruvate (HP:0003542) | 2.43853243 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.41061750 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.40943430 |
| 61 | Opisthotonus (HP:0002179) | 2.40806599 |
| 62 | Vomiting (HP:0002013) | 2.38184650 |
| 63 | Vertebral compression fractures (HP:0002953) | 2.37299045 |
| 64 | Abnormality of serum amino acid levels (HP:0003112) | 2.35959197 |
| 65 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.35427477 |
| 66 | Complement deficiency (HP:0004431) | 2.34037292 |
| 67 | Abnormal hemoglobin (HP:0011902) | 2.34004844 |
| 68 | Xanthomatosis (HP:0000991) | 2.26990567 |
| 69 | Abnormal pupillary function (HP:0007686) | 2.26527046 |
| 70 | Ketosis (HP:0001946) | 2.25982502 |
| 71 | Methylmalonic acidemia (HP:0002912) | 2.25868969 |
| 72 | Microvesicular hepatic steatosis (HP:0001414) | 2.25611947 |
| 73 | Abnormality of complement system (HP:0005339) | 2.25372172 |
| 74 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.24269023 |
| 75 | Hypokinesia (HP:0002375) | 2.24215645 |
| 76 | Progressive external ophthalmoplegia (HP:0000590) | 2.23780496 |
| 77 | Sensory axonal neuropathy (HP:0003390) | 2.23304605 |
| 78 | CNS demyelination (HP:0007305) | 2.22553346 |
| 79 | Deep venous thrombosis (HP:0002625) | 2.20657675 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.20161702 |
| 81 | Progressive neurologic deterioration (HP:0002344) | 2.18856615 |
| 82 | Late onset (HP:0003584) | 2.18485545 |
| 83 | Metabolic acidosis (HP:0001942) | 2.17761164 |
| 84 | Conjugated hyperbilirubinemia (HP:0002908) | 2.17526275 |
| 85 | Hypoglycemic coma (HP:0001325) | 2.16805413 |
| 86 | Petechiae (HP:0000967) | 2.14846983 |
| 87 | Abnormality of methionine metabolism (HP:0010901) | 2.14782896 |
| 88 | Neuroendocrine neoplasm (HP:0100634) | 2.10952258 |
| 89 | Microretrognathia (HP:0000308) | 2.10627441 |
| 90 | Pheochromocytoma (HP:0002666) | 2.09937510 |
| 91 | Ileus (HP:0002595) | 2.09905965 |
| 92 | Macrocytic anemia (HP:0001972) | 2.07393994 |
| 93 | Prolonged neonatal jaundice (HP:0006579) | 2.05941832 |
| 94 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.05706164 |
| 95 | Gout (HP:0001997) | 2.04019761 |
| 96 | Malnutrition (HP:0004395) | 2.02651444 |
| 97 | Rough bone trabeculation (HP:0100670) | 2.00446096 |
| 98 | Emotional lability (HP:0000712) | 1.99834148 |
| 99 | Vascular calcification (HP:0004934) | 1.99829437 |
| 100 | Ragged-red muscle fibers (HP:0003200) | 1.97758814 |
| 101 | Renal tubular dysfunction (HP:0000124) | 1.96724656 |
| 102 | Joint hemorrhage (HP:0005261) | 1.96635971 |
| 103 | Alkalosis (HP:0001948) | 1.96375175 |
| 104 | Respiratory difficulties (HP:0002880) | 1.96125877 |
| 105 | Abnormal trabecular bone morphology (HP:0100671) | 1.95063747 |
| 106 | Dysostosis multiplex (HP:0000943) | 1.93295862 |
| 107 | Hydroxyprolinuria (HP:0003080) | 1.92139828 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.92139828 |
| 109 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91484424 |
| 110 | Neoplasm of head and neck (HP:0012288) | 1.90693729 |
| 111 | Esophageal neoplasm (HP:0100751) | 1.90693729 |
| 112 | Glomerulonephritis (HP:0000099) | 1.90314153 |
| 113 | Abnormality of magnesium homeostasis (HP:0004921) | 1.90012649 |
| 114 | Fat malabsorption (HP:0002630) | 1.89277095 |
| 115 | Paraparesis (HP:0002385) | 1.89195872 |
| 116 | Purpura (HP:0000979) | 1.88352900 |
| 117 | X-linked dominant inheritance (HP:0001423) | 1.86377930 |
| 118 | Nausea (HP:0002018) | 1.86163805 |
| 119 | Rhabdomyolysis (HP:0003201) | 1.85800964 |
| 120 | Palpitations (HP:0001962) | 1.85609086 |
| 121 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84902588 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84902588 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84902588 |
| 124 | Hyperlipoproteinemia (HP:0010980) | 1.82395603 |
| 125 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.82373631 |
| 126 | Ketoacidosis (HP:0001993) | 1.82345211 |
| 127 | Delayed CNS myelination (HP:0002188) | 1.81046537 |
| 128 | Abnormality of vitamin B metabolism (HP:0004340) | 1.80543562 |
| 129 | Abnormal number of erythroid precursors (HP:0012131) | 1.79903063 |
| 130 | Abnormality of vitamin metabolism (HP:0100508) | 1.79754949 |
| 131 | Spastic paraparesis (HP:0002313) | 1.77904183 |
| 132 | Hyperbilirubinemia (HP:0002904) | 1.74427493 |
| 133 | Amniotic constriction ring (HP:0009775) | 1.73432771 |
| 134 | Abnormality of placental membranes (HP:0011409) | 1.73432771 |
| 135 | Proximal tubulopathy (HP:0000114) | 1.72740606 |
| 136 | Cholecystitis (HP:0001082) | 1.72490828 |
| 137 | Abnormal gallbladder physiology (HP:0012438) | 1.72490828 |
| 138 | Pancreatitis (HP:0001733) | 1.72155285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.67058947 |
| 2 | VRK2 | 4.06446325 |
| 3 | CASK | 3.69492512 |
| 4 | TNIK | 3.42002470 |
| 5 | BCKDK | 3.29996999 |
| 6 | TLK1 | 3.23683136 |
| 7 | ERN1 | 2.86865852 |
| 8 | EPHA2 | 2.66354308 |
| 9 | STK16 | 2.59248755 |
| 10 | MAP3K12 | 2.48344317 |
| 11 | NME1 | 2.38426327 |
| 12 | MUSK | 2.30746673 |
| 13 | STK39 | 2.21704691 |
| 14 | IRAK3 | 2.06999471 |
| 15 | MST4 | 2.01241706 |
| 16 | MYLK | 1.93681909 |
| 17 | MAPKAPK3 | 1.88752417 |
| 18 | PIM2 | 1.85278648 |
| 19 | ARAF | 1.84814964 |
| 20 | PBK | 1.83619233 |
| 21 | WNK4 | 1.70021333 |
| 22 | ILK | 1.68250421 |
| 23 | GRK7 | 1.67150775 |
| 24 | TRIB3 | 1.63566240 |
| 25 | MST1R | 1.60564372 |
| 26 | ADRBK2 | 1.57744459 |
| 27 | PAK4 | 1.50879828 |
| 28 | GRK5 | 1.50192797 |
| 29 | OXSR1 | 1.48404176 |
| 30 | TESK2 | 1.43828077 |
| 31 | TAOK2 | 1.38311975 |
| 32 | MKNK2 | 1.37688915 |
| 33 | EIF2AK3 | 1.33513502 |
| 34 | PRKCI | 1.31724515 |
| 35 | IRAK1 | 1.30987569 |
| 36 | SIK1 | 1.30473627 |
| 37 | MAPKAPK5 | 1.25149828 |
| 38 | DAPK1 | 1.23998972 |
| 39 | MAP2K2 | 1.23772865 |
| 40 | CDK19 | 1.23114079 |
| 41 | TAOK1 | 1.22314251 |
| 42 | MAP2K6 | 1.21026063 |
| 43 | IRAK4 | 1.20292717 |
| 44 | PRKD3 | 1.19353283 |
| 45 | MAP3K3 | 1.17391655 |
| 46 | PIK3CG | 1.14773811 |
| 47 | MAP2K7 | 1.13410085 |
| 48 | SMG1 | 1.10488499 |
| 49 | NLK | 1.10008929 |
| 50 | FES | 1.09521961 |
| 51 | PINK1 | 1.07581596 |
| 52 | MAPK15 | 1.06661617 |
| 53 | PIK3CA | 1.06005823 |
| 54 | EIF2AK1 | 1.04421359 |
| 55 | BRAF | 1.02852594 |
| 56 | MAP3K11 | 1.02663416 |
| 57 | BLK | 0.99164759 |
| 58 | PRKG2 | 0.98729724 |
| 59 | TEC | 0.98645278 |
| 60 | IRAK2 | 0.97360389 |
| 61 | LIMK1 | 0.96824859 |
| 62 | CAMK2D | 0.96027797 |
| 63 | OBSCN | 0.95565190 |
| 64 | ABL2 | 0.91893347 |
| 65 | CAMK2G | 0.90259786 |
| 66 | LRRK2 | 0.89715661 |
| 67 | CAMK2B | 0.84010189 |
| 68 | SCYL2 | 0.83882437 |
| 69 | PDK2 | 0.82801406 |
| 70 | BMPR1B | 0.80294628 |
| 71 | BRSK1 | 0.80286064 |
| 72 | VRK1 | 0.79474279 |
| 73 | PRKD2 | 0.76009067 |
| 74 | LMTK2 | 0.72858214 |
| 75 | DAPK3 | 0.69055101 |
| 76 | BMPR2 | 0.68252476 |
| 77 | EPHB2 | 0.67709011 |
| 78 | CSNK1G3 | 0.67384079 |
| 79 | ADRBK1 | 0.62737063 |
| 80 | SRPK1 | 0.62722892 |
| 81 | RPS6KB2 | 0.62277439 |
| 82 | MAPK11 | 0.60337148 |
| 83 | CSNK1G1 | 0.59806050 |
| 84 | MAP4K1 | 0.59754761 |
| 85 | NEK1 | 0.58689039 |
| 86 | TBK1 | 0.58578574 |
| 87 | MAPK4 | 0.57995281 |
| 88 | PTK2 | 0.57860193 |
| 89 | CDK8 | 0.56987800 |
| 90 | CAMK2A | 0.56714249 |
| 91 | AURKA | 0.56376587 |
| 92 | YES1 | 0.54359361 |
| 93 | TYK2 | 0.54224836 |
| 94 | ERBB4 | 0.53651892 |
| 95 | PAK1 | 0.52954358 |
| 96 | AKT3 | 0.52633168 |
| 97 | PRKACA | 0.52376720 |
| 98 | MAP3K1 | 0.51674855 |
| 99 | MAP2K4 | 0.51587501 |
| 100 | PDPK1 | 0.50926876 |
| 101 | PHKG2 | 0.50366398 |
| 102 | PHKG1 | 0.50366398 |
| 103 | MAPK13 | 0.49903115 |
| 104 | CAMKK2 | 0.48574124 |
| 105 | FLT3 | 0.48325860 |
| 106 | KDR | 0.48310415 |
| 107 | TXK | 0.48202474 |
| 108 | CDK7 | 0.47618265 |
| 109 | CSK | 0.47416111 |
| 110 | BUB1 | 0.47144581 |
| 111 | MAP2K3 | 0.46782641 |
| 112 | MAP3K8 | 0.46223673 |
| 113 | GRK1 | 0.45288135 |
| 114 | TGFBR2 | 0.44112439 |
| 115 | PTK6 | 0.43294991 |
| 116 | NEK9 | 0.43262482 |
| 117 | IKBKB | 0.42092943 |
| 118 | PKN1 | 0.41508294 |
| 119 | TESK1 | 0.40864830 |
| 120 | ZAP70 | 0.40607296 |
| 121 | PRKAA2 | 0.38552315 |
| 122 | GRK6 | 0.38364046 |
| 123 | TIE1 | 0.38305408 |
| 124 | CSNK2A1 | 0.37192980 |
| 125 | INSRR | 0.36413989 |
| 126 | IKBKE | 0.35068418 |
| 127 | MAPK12 | 0.34687181 |
| 128 | CSNK2A2 | 0.34528806 |
| 129 | CLK1 | 0.33219598 |
| 130 | RPS6KA5 | 0.33098526 |
| 131 | PRKCE | 0.32078372 |
| 132 | CSNK1A1L | 0.31836007 |
| 133 | MATK | 0.31676965 |
| 134 | MET | 0.31550025 |
| 135 | UHMK1 | 0.30894251 |
| 136 | PRKCA | 0.30647144 |
| 137 | TNK2 | 0.30594237 |
| 138 | MKNK1 | 0.29534431 |
| 139 | MAPKAPK2 | 0.25374029 |
| 140 | CSNK1G2 | 0.24947750 |
| 141 | AURKB | 0.24337848 |
| 142 | CDK11A | 0.23622522 |
| 143 | CSNK1A1 | 0.23599615 |
| 144 | PRKCD | 0.23141321 |
| 145 | PRKD1 | 0.23061927 |
| 146 | PKN2 | 0.21059336 |
| 147 | MOS | 0.18992427 |
| 148 | DMPK | 0.17837199 |
| 149 | STK10 | 0.17700427 |
| 150 | BMX | 0.16753476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.25762914 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.57437117 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.83438482 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 2.59550760 |
| 5 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.42559514 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.38609634 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.31870228 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.25240889 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.17833200 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.17462507 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.08743509 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.07376703 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.02724882 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02672874 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95599525 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93638706 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91363075 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91267767 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85504672 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.84807258 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.83534828 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81166661 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76418345 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.76367349 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69287730 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68803514 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67265472 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59426263 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56021456 |
| 30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.54083098 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52198039 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46087233 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41309247 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40775457 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.40633818 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31006687 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.30392490 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29221158 |
| 39 | Proteasome_Homo sapiens_hsa03050 | 1.27592679 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24659596 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22905081 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21160479 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20043562 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19488999 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18732522 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18712854 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17608985 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.14711544 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14392155 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12628751 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.12038513 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11803675 |
| 53 | DNA replication_Homo sapiens_hsa03030 | 1.11668783 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11355027 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08002853 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06982625 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06941035 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 1.03857850 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00893365 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 0.99511599 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96335817 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92645664 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92540509 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87802941 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.87174949 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84218639 |
| 67 | RNA polymerase_Homo sapiens_hsa03020 | 0.81081946 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77200449 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76162946 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75943993 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75895182 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74265451 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72305533 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.71581426 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68578713 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67256014 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65516577 |
| 78 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65423560 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64675865 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59355753 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58610174 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58031979 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56456293 |
| 84 | Mismatch repair_Homo sapiens_hsa03430 | 0.56298000 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56081263 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55717436 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54829192 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54823830 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54745221 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49771814 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.49163911 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48954771 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47662231 |
| 94 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47488465 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.42572813 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42306212 |
| 97 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41670468 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40927280 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38433512 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.34244643 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33738752 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.33573256 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31339684 |
| 104 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29959562 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28133075 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.27557170 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27521418 |
| 108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.25531729 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24736904 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.24197055 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.23651430 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22638515 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.21553422 |
| 114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.19666450 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19353737 |
| 116 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.19056516 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18605893 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14555205 |

